L, distilled H2O: 32.25 ml) and incubated for 60 minutes at 37uC. FITC-dUTP-labeled cells were analyzed by the flow cytometry with a 520 nm Argon laser.Immunoblot AnalysisCell lysates were prepared from tumor tissues using a whole cell lysis buffer (Mammalian Protein Extraction Reagent; Thermo Scientific, Rockford, IL, USA) supplemented with protease and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN, USA). Mitochondrial order Enasidenib fractions and cytoplasmic fractions were isolated using the Mitochondria Isolation Kit according to manufacturer’s protocol (Thermo Scientific), Protein concentration was quantified using the Bradford Protein Assay reagent (BioRad, Richmond, CA, USA) and samples were processed using standard western immunoblotting procedures [39]. Membranes were incubated overnight at 4uC with the following antibodies in Can Get Signal Solution 1 (TOYOBO Co., LTD, Osaka, Japan): anti-human purchase EPZ015666 cleaved caspase 3 antibody (1:1000) (Cell Signaling Technology, Danvers, MA, USA), anti-human cleaved caspase 9 antibody (1:1000) (Cell Signaling Technology), anti-human cleaved PARP antibody (1:1000) (Cell Signaling Technology), anti-human cytochrome c antibody (1:1000) (eBiosience Inc., San Diego, CA, USA), anti-human Bax antibody (1:1000) (Cell Signaling Technology) and anti-human a-tubulin antibody (1:2000) (Sigma-Aldrich). Following washes, membranes were incubated with the appropriate secondary antibody conjugated to horseradish peroxidase, and exposed with ECL Plus WesternImmunofluorescence StainingTo assess the mitochondrial proliferation and the apoptotic activity in treated tumors, we performed the immunofluorescence staining using the MitoTracker Deep Red FM (Invitrogen) and the APO-DIRECT Kit (BD Pharmingen, Franklin Lakes, NJ, USA) following the manufacturer’s protocol, respectively. The nucleus was stained with DAPI. The images were obtained using a BZ8000 confocal microscope (Keyence).DNA Fragmentation AnalysisDNA fragmentation was evaluated using the APO-DIRECT Kit according to the manufacturer’s protocol (BD Pharmingen). Briefly, implanted tumors were excised, minced and filtered through a cell strainer (BD Falcon, Bedford, MA, USA) to obtain a single cell suspension. Erythrocytes were lysed in BD Pharm LyseTM Lysing Buffer (BD Pharmingen) and the remaining cellsCO2 Induces Mitochondrial Apoptosis in Cancersblotting detection system reagent (GE Healthcare Bio-Sciences, Piscataway, NJ, USA). The signals were detected using the Chemilumino analyzer LAS-3000 mini (Fujifilm, Tokyo, Japan).Measurement of Intracellular Ca2+To investigate the effect of transcutaneous CO2 treatment on intracellular Ca2+ in MFH tumor tissues, we isolated implanted tumors from mice at 0 (n = 12), 6 (n = 6) 15900046 and 24 hours (n = 12) after our transcutaneous CO2 treatment, and evaluated the intracellular Ca2+ concentration using Calcium Assay Kit according to the manufacturer’s protocol (Cayman Chemical Company, Ann Arbor, Michigan, USA). Briefly, implanted tumors were excised, minced and rinsed with PBS containing 0.16 mg/ml heparin to remove any extraneous red blood cells and clots, and the tissues were homogenized in PBS containing 0.16 mg/ml heparin. Suspensions were centrifuged at 100006g for 15 minutes at 4uC, and the supernatant was removed. Then, the detector was added, and the optical density was measured at a wavelength of 570 nm using a Model 680 Microplate Reader (Bio-Rad) after 5 minutes of incubation. The relative number of Ca2+ concent.L, distilled H2O: 32.25 ml) and incubated for 60 minutes at 37uC. FITC-dUTP-labeled cells were analyzed by the flow cytometry with a 520 nm Argon laser.Immunoblot AnalysisCell lysates were prepared from tumor tissues using a whole cell lysis buffer (Mammalian Protein Extraction Reagent; Thermo Scientific, Rockford, IL, USA) supplemented with protease and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN, USA). Mitochondrial fractions and cytoplasmic fractions were isolated using the Mitochondria Isolation Kit according to manufacturer’s protocol (Thermo Scientific), Protein concentration was quantified using the Bradford Protein Assay reagent (BioRad, Richmond, CA, USA) and samples were processed using standard western immunoblotting procedures [39]. Membranes were incubated overnight at 4uC with the following antibodies in Can Get Signal Solution 1 (TOYOBO Co., LTD, Osaka, Japan): anti-human cleaved caspase 3 antibody (1:1000) (Cell Signaling Technology, Danvers, MA, USA), anti-human cleaved caspase 9 antibody (1:1000) (Cell Signaling Technology), anti-human cleaved PARP antibody (1:1000) (Cell Signaling Technology), anti-human cytochrome c antibody (1:1000) (eBiosience Inc., San Diego, CA, USA), anti-human Bax antibody (1:1000) (Cell Signaling Technology) and anti-human a-tubulin antibody (1:2000) (Sigma-Aldrich). Following washes, membranes were incubated with the appropriate secondary antibody conjugated to horseradish peroxidase, and exposed with ECL Plus WesternImmunofluorescence StainingTo assess the mitochondrial proliferation and the apoptotic activity in treated tumors, we performed the immunofluorescence staining using the MitoTracker Deep Red FM (Invitrogen) and the APO-DIRECT Kit (BD Pharmingen, Franklin Lakes, NJ, USA) following the manufacturer’s protocol, respectively. The nucleus was stained with DAPI. The images were obtained using a BZ8000 confocal microscope (Keyence).DNA Fragmentation AnalysisDNA fragmentation was evaluated using the APO-DIRECT Kit according to the manufacturer’s protocol (BD Pharmingen). Briefly, implanted tumors were excised, minced and filtered through a cell strainer (BD Falcon, Bedford, MA, USA) to obtain a single cell suspension. Erythrocytes were lysed in BD Pharm LyseTM Lysing Buffer (BD Pharmingen) and the remaining cellsCO2 Induces Mitochondrial Apoptosis in Cancersblotting detection system reagent (GE Healthcare Bio-Sciences, Piscataway, NJ, USA). The signals were detected using the Chemilumino analyzer LAS-3000 mini (Fujifilm, Tokyo, Japan).Measurement of Intracellular Ca2+To investigate the effect of transcutaneous CO2 treatment on intracellular Ca2+ in MFH tumor tissues, we isolated implanted tumors from mice at 0 (n = 12), 6 (n = 6) 15900046 and 24 hours (n = 12) after our transcutaneous CO2 treatment, and evaluated the intracellular Ca2+ concentration using Calcium Assay Kit according to the manufacturer’s protocol (Cayman Chemical Company, Ann Arbor, Michigan, USA). Briefly, implanted tumors were excised, minced and rinsed with PBS containing 0.16 mg/ml heparin to remove any extraneous red blood cells and clots, and the tissues were homogenized in PBS containing 0.16 mg/ml heparin. Suspensions were centrifuged at 100006g for 15 minutes at 4uC, and the supernatant was removed. Then, the detector was added, and the optical density was measured at a wavelength of 570 nm using a Model 680 Microplate Reader (Bio-Rad) after 5 minutes of incubation. The relative number of Ca2+ concent.